Topical glucocorticosteroids in rhinitis: Mode of action

Acta Oto-Laryngologica

Volumn 126, Issue 7, 2006, Pages 676-678

  Mygind, Niels ^a   Andersson, Morgan ^b  

^a LILLEBAELT HOSPITAL   (Denmark)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; GLUCOCORTICOID; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8;

CLINICAL FEATURE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DRUG MECHANISM; HUMAN; HUMAN CELL; HUMAN TISSUE; MAST CELL; NOSE MUCOSA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RESPIRATORY TRACT MUCOSA; REVIEW; RHINITIS;

ADMINISTRATION, TOPICAL; BASOPHILS; CYTOKINES; EOSINOPHILS; GLUCOCORTICOIDS; HUMANS; IMMUNOGLOBULIN E; LYMPHOCYTES; MAST CELLS; RHINITIS; VASOCONSTRICTION;

EID: 33745726817     PISSN: 00016489     EISSN: 16512553     Source Type: Journal    
DOI: 10.1080/00016480500469032     Document Type: Review

References (23)

1. Mygind N. Local effect of intranasal beclomethasone dipropionate aerosol in hay fever. BMJ 1973;4:464-6.
2. Pipkorn U. Budesonide and nasal histamine challenge. Allergy 1982;37:359-63.
3. Pipkorn U, Enerbäck L. Nasal mucosal mast cells and histamine in hay fever: effect of topical glucocorticoid treatment. Int Arch Allergy Appl Immunol 1987;84:123-8.
4. Gomez E, Clague J, Gatland D, Davies R. Effect of topical corticosteroids on seasonally induced increase in nasal mast cells. BMJ 1988;246:1572-3.
5. Bascom R, Wachs M, Naclerio RM, Pipkorn U, Galli S, Lichtenstein LM. Basophil influx occurs after nasal antigen challenge: effects of topical corticosteroid pretreatment. J Allergy Clin Immunol 1988;81:580-9.
6. Bascom R, Pipkorn U, Lichtenstein LM, Naclerio RM. The influx of inflammatory cells into nasal washings during the late response to antigen challenge. Effect of systemic corticosteroids. Am Rev Respir Dis 1988;138:406-12.
7. Klementsson H, Svensson C, Andersson M, Venge P, Pipkorn U, Persson CG. Eosinophils, secretory responsiveness and glucocorticoid-induced effects on the nasal mucosa during a weak pollen season. Clin Exp Allergy 1991;21:705-10.
8. Kay AB. Asthma and inflammation. J Allergy Clin Immunol 1991;87:893-910.
9. Rak S, Jacobson MR, Sudderick RM, Masuyama K, Kay AB, Hamid Q, et al. Influence of prolonged treatment with topical corticosteroid (fluticasone propionate) on early and late phase nasal responses and cellular infiltration in the nasal mucosa after allergen challenge. Clin Exp Allergy 1994;24: 930-9.
10. Masuyama K, Rak S, Jacobson MR, Löwhagen O, Hamid Q, Durham SR. Rhinitis at the cellular level. Eur Respir Rev 1994;4:252-5.
11. Kanai N, Denburg JA, Evans S, Conway M, Jordana M, Dolovich J. Nasal polyp inflammation. Effect of topical nasal steroid. Am J Respir Crit Care Med 1994;150:1094-100.
12. Cox G, Ohtoshi T, Vancheri C, Denburg J, Dolovich J, Gauldie J, et al. Promotion of eosinophil survival by human bronchial epithelial cells and its modulation by steroids. Am J Respir Cell Mol Biol 1991;4:525-31.
13. Holt P. Immune tolerance and protection against allergic sensitization. Allergy 1995;50(Suppl 25):34-6.
14. Pawankar RU, Okuda M, Hasegawa S, Suzuki K, Yssel H, Okuba K, et al. Interleukin-13 expression in the nasal mucosa of perennial allergic rhinitis. Am J Respir Crit Care Med 1995;152:2059-67.
15. Naclerio RM, Adkinson NF Jr, Creticos PS, Baroody FM, Hamilton RG, Norman PS. Intranasal steroids inhibit seasonal increase in ragweed-induced immunoglobulin E antibodies. J Allergy Clin Immunol 1993;92:517-21.
16. Karlsson MG, Davidsson A, Viale G, Graziani D, Hellquist HB. Nasal messenger RNA expression of interleukins 2, 4 and 5 in patients with allergic rhinitis. Diagn Mol Pathol 1995;4:85-92.
17. Holm AF, Fokkens WJ, Godthelp T, Mulder PGH, Vroom TM, Rijntjes E. Effect of 3 months' nasal steroid therapy on nasal T cells and Langerhans cells in patients suffering from allergic rhinitis. Allergy 1995;50:204-9.
18. 133Xe wash-out technique. Allergy 1983;38:461-4.
19. Persson CGA, Erjefält JS, Andersson M, Greiff L, Svensson C. Microvascular-epithelial exudation of bulk plasma in airway defence, disease, and repair. In: Holgate ST, Busse WW, editors. Inflammatory mechanisms in asthma. New York: Marcel Dekker; 1998. p. 599-617.
20. Pipkorn U, Proud D, Lichtenstein LM, Kagey-Sobotka A, Norman PS, Naclerio RM. Inhibition of mediator release in allergic rhinitis by pretreatment with topical gluco-corticosteroids. N Engl J Med 1987;316:1506-10.
21. Svensson C, Klementsson H, Andersson M, Pipkorn U, Alkner U, Persson CGA. Glucocorticoid-induced attenuation of mucosal exudation of fibrinogen and bradykinins in seasonal allergic rhinitis. Allergy 1994;49:177-83.
22. Andersson M, Andersson P, Pipkorn U. Topical glucocorticosteroids and allergen-induced increase in nasal reactivity. Relationship between treatment time and inhibitory effect. J Allergy Clin Immunol 1988;82:1019-26.
23. Andersson M, Andersson P, Pipkorn U. Allergen-induced specific and non-specific nasal hyperreactivity. Reciprocal relationship and inhibition by topical glucocorticosteroids. Acta Otolaryngol (Stockh) 1989;107:270-7.